ID   MRP2_RAT                Reviewed;        1541 AA.
AC   Q63120; Q63145;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 173.
DE   RecName: Full=ATP-binding cassette sub-family C member 2;
DE            EC=7.6.2.- {ECO:0000269|PubMed:10421658, ECO:0000269|PubMed:11248200};
DE            EC=7.6.2.2 {ECO:0000269|PubMed:10220572};
DE            EC=7.6.2.3 {ECO:0000269|PubMed:10220572, ECO:0000269|PubMed:8662992};
DE   AltName: Full=Canalicular multidrug resistance protein;
DE   AltName: Full=Canalicular multispecific organic anion transporter 1 {ECO:0000305};
DE   AltName: Full=Multidrug resistance-associated protein 2 {ECO:0000250|UniProtKB:Q92887};
GN   Name=Abcc2 {ECO:0000312|RGD:2366};
GN   Synonyms=Cmoat, Cmrp {ECO:0000303|PubMed:8662992}, Mrp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8599091; DOI=10.1126/science.271.5252.1126;
RA   Paulusma C.C., Bosma P.J., Zaman G.J.R., Bakker C.T.M., Otter M.,
RA   Scheffer G.L., Scheper R.J., Borst P., Oude Elferink R.P.J.;
RT   "Congenital jaundice in rats with a mutation in a multidrug resistance-
RT   associated protein gene.";
RL   Science 271:1126-1128(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN EHBR, FUNCTION, CATALYTIC
RP   ACTIVITY, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8662992; DOI=10.1074/jbc.271.25.15091;
RA   Buechler M., Koenig J., Brom M., Kartenbeck J., Spring H., Horie T.,
RA   Keppler D.;
RT   "cDNA cloning of the hepatocyte canalicular isoform of the multidrug
RT   resistance protein, cMrp, reveals a novel conjugate export pump deficient
RT   in hyperbilirubinemic mutant rats.";
RL   J. Biol. Chem. 271:15091-15098(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INVOLVEMENT IN EHBR.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RA   Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y.;
RT   "Expression of the putative ATP-binding cassette region, homologous to that
RT   in multidrug resistance associated protein (MRP), is hereditarily defective
RT   in Eisai hyperbilirubinemic rats (EHBR).";
RL   Int. Hepatol. Commun. 292:292-299(1996).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-279; SER-281 AND SER-874, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10421658; DOI=10.1002/hep.510300220;
RA   Kamisako T., Leier I., Cui Y., Koenig J., Buchholz U.,
RA   Hummel-Eisenbeiss J., Keppler D.;
RT   "Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant
RT   human and rat multidrug resistance protein 2.";
RL   Hepatology 30:485-490(1999).
RN   [6]
RP   CATALYTIC ACTIVITY, FUNCTION, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=10220572;
RA   Cui Y., Koenig J., Buchholz J.K., Spring H., Leier I., Keppler D.;
RT   "Drug resistance and ATP-dependent conjugate transport mediated by the
RT   apical multidrug resistance protein, MRP2, permanently expressed in human
RT   and canine cells.";
RL   Mol. Pharmacol. 55:929-937(1999).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11248200; DOI=10.1016/s0005-2736(00)00355-2;
RA   Akita H., Suzuki H., Ito K., Kinoshita S., Sato N., Takikawa H.,
RA   Sugiyama Y.;
RT   "Characterization of bile acid transport mediated by multidrug resistance
RT   associated protein 2 and bile salt export pump.";
RL   Biochim. Biophys. Acta 1511:7-16(2001).
CC   -!- FUNCTION: ATP-dependent transporter of the ATP-binding cassette (ABC)
CC       family that binds and hydrolyzes ATP to enable active transport of
CC       various substrates including many drugs, toxicants and endogenous
CC       compound across cell membranes. Transports a wide variety of conjugated
CC       organic anions such as sulfate-, glucuronide- and glutathione (GSH)-
CC       conjugates of endo- and xenobiotics substrates (PubMed:10220572,
CC       PubMed:10421658, PubMed:11248200, PubMed:8662992). Mediates
CC       hepatobiliary excretion of mono- and bis-glucuronidated bilirubin
CC       molecules and therefore play an important role in bilirubin
CC       detoxification (PubMed:10421658). Mediates also hepatobiliary excretion
CC       of others glucuronide conjugates such as 17beta-estradiol 17-
CC       glucosiduronic acid and leukotriene C4 (PubMed:10220572,
CC       PubMed:8662992). Transports sulfated bile salt such as
CC       taurolithocholate sulfate (PubMed:11248200). Transports various
CC       anticancer drugs, such as anthracycline, vinca alkaloid and
CC       methotrexate and HIV-drugs such as protease inhibitors (By similarity).
CC       {ECO:0000250|UniProtKB:Q92887, ECO:0000269|PubMed:10220572,
CC       ECO:0000269|PubMed:10421658, ECO:0000269|PubMed:11248200,
CC       ECO:0000269|PubMed:8662992}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted glutathione(in) + ATP + H2O = ADP + an S-
CC         substituted glutathione(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:19121, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:90779,
CC         ChEBI:CHEBI:456216; EC=7.6.2.3;
CC         Evidence={ECO:0000269|PubMed:10220572, ECO:0000269|PubMed:8662992};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19122;
CC         Evidence={ECO:0000305|PubMed:10220572, ECO:0000305|PubMed:8662992};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + taurolithocholate 3-sulfate(in) = ADP + H(+) +
CC         phosphate + taurolithocholate 3-sulfate(out); Xref=Rhea:RHEA:50084,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58301, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:11248200};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50085;
CC         Evidence={ECO:0000269|PubMed:11248200};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate +
CC         xenobioticSide 2.; EC=7.6.2.2;
CC         Evidence={ECO:0000269|PubMed:10220572};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol 17-O-(beta-D-glucuronate)(in) + ATP + H2O =
CC         17beta-estradiol 17-O-(beta-D-glucuronate)(out) + ADP + H(+) +
CC         phosphate; Xref=Rhea:RHEA:60128, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:82961, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10220572};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60129;
CC         Evidence={ECO:0000269|PubMed:10220572};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + leukotriene C4(in) = ADP + H(+) + leukotriene
CC         C4(out) + phosphate; Xref=Rhea:RHEA:38963, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57973, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10220572, ECO:0000269|PubMed:8662992};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38964;
CC         Evidence={ECO:0000305|PubMed:10220572};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha C8-beta-D-glucuronoside(in) + ATP +
CC         H2O = (4Z,15Z)-bilirubin IXalpha C8-beta-D-glucuronoside(out) + ADP +
CC         H(+) + phosphate; Xref=Rhea:RHEA:66180, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:229704, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:10421658};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66181;
CC         Evidence={ECO:0000305|PubMed:10421658};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,15Z)-bilirubin IXalpha C8,C12-beta-D-bisglucuronoside(in)
CC         + ATP + H2O = (4Z,15Z)-bilirubin IXalpha C8,C12-beta-D-
CC         bisglucuronoside(out) + ADP + H(+) + phosphate; Xref=Rhea:RHEA:66192,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:229706, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000305|PubMed:10421658};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.9 uM for taurolithocholate 3-sulfate
CC         {ECO:0000269|PubMed:11248200};
CC         KM=6.9 uM for 17beta-estradiol 17-O-(beta-D-glucuronate)
CC         {ECO:0000269|PubMed:10220572};
CC         KM=1.1 uM for leukotriene C4 {ECO:0000269|PubMed:10220572};
CC         KM=0.8 uM for bilirubin-glucuronoside {ECO:0000269|PubMed:10421658};
CC         KM=0.5 uM for bilirubin-bisglucuronoside
CC         {ECO:0000269|PubMed:10421658};
CC         Vmax=1486 pmol/min/mg enzyme for taurolithocholate 3-sulfate
CC         {ECO:0000269|PubMed:11248200};
CC         Vmax=152 pmol/min/mg enzyme for bilirubin-glucuronoside transport
CC         {ECO:0000269|PubMed:10421658};
CC         Vmax=264 pmol/min/mg enzyme bilirubin-bisglucuronoside transport
CC         {ECO:0000269|PubMed:10421658};
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:10220572, ECO:0000269|PubMed:8662992}; Multi-pass
CC       membrane protein {ECO:0000255}. Note=Localized to the canalicular
CC       membrane of hepatocytes. {ECO:0000269|PubMed:8662992}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in the liver.
CC       {ECO:0000269|PubMed:8662992}.
CC   -!- DISEASE: Note=Defects in Abcc2 are a cause of hereditary conjugated
CC       hyperbilirubinemia (EHBR). {ECO:0000269|PubMed:8599091,
CC       ECO:0000269|Ref.3}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC family.
CC       Conjugate transporter (TC 3.A.1.208) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L49379; AAC42087.1; -; mRNA.
DR   EMBL; X96393; CAA65257.1; -; mRNA.
DR   EMBL; D86086; BAA13016.1; -; mRNA.
DR   PIR; S71839; S71839.
DR   RefSeq; NP_036965.1; NM_012833.2.
DR   PDB; 8RQ3; EM; 3.21 A; A=1-1541.
DR   PDB; 8RQ4; EM; 3.45 A; A=1-1541.
DR   PDBsum; 8RQ3; -.
DR   PDBsum; 8RQ4; -.
DR   AlphaFoldDB; Q63120; -.
DR   EMDB; EMD-19431; -.
DR   EMDB; EMD-19433; -.
DR   SMR; Q63120; -.
DR   BioGRID; 247342; 1.
DR   IntAct; Q63120; 2.
DR   MINT; Q63120; -.
DR   STRING; 10116.ENSRNOP00000064799; -.
DR   BindingDB; Q63120; -.
DR   ChEMBL; CHEMBL2073676; -.
DR   CarbonylDB; Q63120; -.
DR   GlyCosmos; Q63120; 4 sites, No reported glycans.
DR   GlyGen; Q63120; 4 sites.
DR   iPTMnet; Q63120; -.
DR   PhosphoSitePlus; Q63120; -.
DR   PaxDb; 10116-ENSRNOP00000064799; -.
DR   Ensembl; ENSRNOT00000070861.3; ENSRNOP00000064799.1; ENSRNOG00000046727.3.
DR   Ensembl; ENSRNOT00055006662; ENSRNOP00055005100; ENSRNOG00055004149.
DR   Ensembl; ENSRNOT00060046915; ENSRNOP00060039014; ENSRNOG00060026873.
DR   Ensembl; ENSRNOT00065049865; ENSRNOP00065040950; ENSRNOG00065028827.
DR   GeneID; 25303; -.
DR   KEGG; rno:25303; -.
DR   AGR; RGD:2366; -.
DR   CTD; 1244; -.
DR   RGD; 2366; Abcc2.
DR   eggNOG; KOG0054; Eukaryota.
DR   GeneTree; ENSGT00940000161741; -.
DR   HOGENOM; CLU_000604_27_3_1; -.
DR   InParanoid; Q63120; -.
DR   OrthoDB; 3384185at2759; -.
DR   PhylomeDB; Q63120; -.
DR   BRENDA; 7.6.2.3; 5301.
DR   Reactome; R-RNO-189483; Heme degradation.
DR   Reactome; R-RNO-382556; ABC-family proteins mediated transport.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   Reactome; R-RNO-9754706; Atorvastatin ADME.
DR   SABIO-RK; Q63120; -.
DR   PRO; PR:Q63120; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000046727; Expressed in liver and 10 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0046581; C:intercellular canaliculus; ISO:RGD.
DR   GO; GO:0046691; C:intracellular canaliculus; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0015431; F:ABC-type glutathione S-conjugate transporter activity; IMP:UniProtKB.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; IMP:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015127; F:bilirubin transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; TAS:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0016999; P:antibiotic metabolic process; IMP:RGD.
DR   GO; GO:1901086; P:benzylpenicillin metabolic process; IMP:RGD.
DR   GO; GO:0015721; P:bile acid and bile salt transport; IEP:RGD.
DR   GO; GO:0015723; P:bilirubin transport; IMP:UniProtKB.
DR   GO; GO:0015722; P:canalicular bile acid transport; IMP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071354; P:cellular response to interleukin-6; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0050787; P:detoxification of mercury ion; IMP:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0030644; P:intracellular chloride ion homeostasis; IDA:RGD.
DR   GO; GO:0071716; P:leukotriene transport; IMP:UniProtKB.
DR   GO; GO:0015694; P:mercury ion transport; IMP:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0015711; P:organic anion transport; IMP:RGD.
DR   GO; GO:0015732; P:prostaglandin transport; IMP:RGD.
DR   GO; GO:0120188; P:regulation of bile acid secretion; IEP:RGD.
DR   GO; GO:0097327; P:response to antineoplastic agent; IEP:RGD.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IDA:RGD.
DR   GO; GO:0033762; P:response to glucagon; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0070327; P:thyroid hormone transport; IMP:RGD.
DR   GO; GO:0070633; P:transepithelial transport; IMP:ARUK-UCL.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   GO; GO:0042178; P:xenobiotic catabolic process; IMP:RGD.
DR   GO; GO:1990961; P:xenobiotic detoxification by transmembrane export across the plasma membrane; IMP:RGD.
DR   GO; GO:0046618; P:xenobiotic export from cell; ISO:RGD.
DR   GO; GO:0006855; P:xenobiotic transmembrane transport; IMP:UniProtKB.
DR   GO; GO:1990962; P:xenobiotic transport across blood-brain barrier; IMP:ARUK-UCL.
DR   CDD; cd18595; ABC_6TM_MRP1_2_3_6_D1_like; 1.
DR   CDD; cd18603; ABC_6TM_MRP1_2_3_6_D2_like; 1.
DR   CDD; cd03250; ABCC_MRP_domain1; 1.
DR   CDD; cd03244; ABCC_MRP_domain2; 1.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR050173; ABC_transporter_C.
DR   InterPro; IPR005292; MRP.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR00957; MRP_assoc_pro; 1.
DR   PANTHER; PTHR24223; ATP-BINDING CASSETTE SUB-FAMILY C; 1.
DR   PANTHER; PTHR24223:SF176; ATP-BINDING CASSETTE SUB-FAMILY C MEMBER 2; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell membrane; Glycoprotein; Lipid transport;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Translocase; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1541
FT                   /note="ATP-binding cassette sub-family C member 2"
FT                   /id="PRO_0000093359"
FT   TOPO_DOM        1..26
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        27..47
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        48..67
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        68..88
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        89..92
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        93..113
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        114..125
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        126..146
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        147..164
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        165..185
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        186..309
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        310..330
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        331..356
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        357..377
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        378..433
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        434..454
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        455..457
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        458..478
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        479..540
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        541..561
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        562..583
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        584..604
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        605..967
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        968..988
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        989..1029
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1030..1050
FT                   /note="Helical; Name=13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1051..1093
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1094..1114
FT                   /note="Helical; Name=14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1115
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1116..1136
FT                   /note="Helical; Name=15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1137..1207
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1208..1228
FT                   /note="Helical; Name=16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1229..1230
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1231..1251
FT                   /note="Helical; Name=17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1252..1541
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   DOMAIN          318..601
FT                   /note="ABC transmembrane type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          633..857
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          975..1260
FT                   /note="ABC transmembrane type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          1296..1530
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          862..881
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          901..923
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         667..674
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         1330..1337
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   MOD_RES         279
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         874
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         922
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92887"
FT   MOD_RES         926
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92887"
FT   MOD_RES         1434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92887"
FT   CARBOHYD        6
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1007
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1010
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1011
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        420
FT                   /note="M -> V (in Ref. 3; BAA13016)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..5
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           12..15
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   STRAND          16..19
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           24..50
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           62..89
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            97..100
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           101..117
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           119..122
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           129..154
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           161..182
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   HELIX           193..195
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           199..203
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            204..208
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           209..217
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            230..232
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   HELIX           234..264
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           306..331
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           332..334
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           335..347
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           354..400
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           405..408
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          409..411
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           413..421
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           423..432
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           433..435
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           436..455
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           456..458
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           459..503
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           505..510
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           514..563
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           572..585
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           588..612
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          621..628
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          630..643
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          649..657
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          663..667
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           673..681
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          684..695
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          697..700
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          708..710
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           711..716
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           723..732
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           736..741
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          742..745
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          749..753
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           759..773
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          776..780
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          785..787
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           789..799
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            805..808
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          809..814
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          818..820
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   HELIX           821..823
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          825..831
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          834..839
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           841..846
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           850..857
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           858..860
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            898..900
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           901..911
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           960..970
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           973..997
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1001..1003
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1009..1011
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1013..1060
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1065..1070
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1073..1081
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1084..1088
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1090..1115
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1117..1121
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1123..1164
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1166..1172
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1175..1224
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            1225..1228
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1231..1241
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1245..1261
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1263..1272
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            1290..1293
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   STRAND          1296..1303
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1305..1309
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1312..1316
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1318..1320
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   STRAND          1325..1329
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1336..1342
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1345..1347
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1349..1356
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1361..1363
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1366..1371
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1384..1386
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1387..1391
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1399..1408
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1412..1415
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1418..1421
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1431..1433
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1435..1449
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1452..1457
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1465..1478
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1482..1487
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1491..1493
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            1494..1496
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   STRAND          1497..1504
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   HELIX           1514..1518
FT                   /evidence="ECO:0007829|PDB:8RQ3"
FT   TURN            1520..1522
FT                   /evidence="ECO:0007829|PDB:8RQ4"
FT   HELIX           1523..1527
FT                   /evidence="ECO:0007829|PDB:8RQ3"
SQ   SEQUENCE   1541 AA;  173384 MW;  D5FB55571BFDDB39 CRC64;
     MDKFCNSTFW DLSLLESPEA DLPLCFEQTV LVWIPLGFLW LLAPWQLYSV YRSRTKRSSI
     TKFYLAKQVF VVFLLILAAI DLSLALTEDT GQATVPPVRY TNPILYLCTW LLVLAVQHSR
     QWCVRKNSWF LSLFWILSVL CGVFQFQTLI RALLKDSKSN MAYSYLFFVS YGFQIVLLIL
     TAFSGPSDST QTPSVTASFL SSITFSWYDR TVLKGYKHPL TLEDVWDIDE GFKTRSVTSK
     FEAAMTKDLQ KARQAFQRRL QKSQRKPEAT LHGLNKKQSQ SQDVLVLEEA KKKSEKTTKD
     YPKSWLIKSL FKTFHVVILK SFILKLIHDL LVFLNPQLLK LLIGFVKSSN SYVWFGYICA
     ILMFAVTLIQ SFCLQSYFQH CFVLGMCVRT TVMSSIYKKA LTLSNLARKQ YTIGETVNLM
     SVDSQKLMDA TNYMQLVWSS VIQITLSIFF LWRELGPSIL AGVGVMVLLI PVNGVLATKI
     RNIQVQNMKN KDKRLKIMNE ILSGIKILKY FAWEPSFQEQ VQGIRKKELK NLLRFGQLQS
     LLIFILQITP ILVSVVTFSV YVLVDSANVL NAEKAFTSIT LFNILRFPLS MLPMVTSSIL
     QASVSVDRLE RYLGGDDLDT SAIRRVSNFD KAVKFSEASF TWDPDLEATI QDVNLDIKPG
     QLVAVVGTVG SGKSSLVSAM LGEMENVHGH ITIQGSTAYV PQQSWIQNGT IKDNILFGSE
     YNEKKYQQVL KACALLPDLE ILPGGDMAEI GEKGINLSGG QKQRVSLARA AYQDADIYIL
     DDPLSAVDAH VGKHIFNKVV GPNGLLAGKT RIFVTHGIHF LPQVDEIVVL GKGTILEKGS
     YRDLLDKKGV FARNWKTFMK HSGPEGEATV NNDSEAEDDD DGLIPTMEEI PEDAASLAMR
     RENSLRRTLS RSSRSSSRRG KSLKNSLKIK NVNVLKEKEK EVEGQKLIKK EFVETGKVKF
     SIYLKYLQAV GWWSILFIIL FYGLNNVAFI GSNLWLSAWT SDSDNLNGTN NSSSHRDMRI
     GVFGALGLAQ GICLLISTLW SIYACRNASK ALHGQLLTNI LRAPMRFFDT TPTGRIVNRF
     SGDISTVDDL LPQTLRSWMM CFFGIAGTLV MICMATPVFA IIIIPLSILY ISVQVFYVAT
     SRQLRRLDSV TKSPIYSHFS ETVTGLPIIR AFEHQQRFLA WNEKQIDINQ KCVFSWITSN
     RWLAIRLELV GNLVVFCSAL LLVIYRKTLT GDVVGFVLSN ALNITQTLNW LVRMTSEAET
     NIVAVERISE YINVENEAPW VTDKRPPADW PRHGEIQFNN YQVRYRPELD LVLKGITCNI
     KSGEKVGVVG RTGAGKSSLT NCLFRILESA GGQIIIDGID VASIGLHDLR ERLTIIPQDP
     ILFSGSLRMN LDPFNKYSDE EVWRALELAH LRSFVSGLQL GLLSEVTEGG DNLSIGQRQL
     LCLGRAVLRK SKILVLDEAT AAVDLETDSL IQTTIRKEFS QCTVITIAHR LHTIMDSDKI
     MVLDNGKIVE YGSPEELLSN RGSFYLMAKE AGIENVNHTE L
//
